Demand For Closed Blood Sampling Systems Is Slated To Experience Significant Growth At 5.9% CAGR By 2032

As per latest revised industry analysis by Fact.MR, a market research and competitive intelligence provider, the global was valued at US$ 72.6 Mn in 2021, and is expected to exhibit a CAGR of 5.9% over the forecast period (2022-2032). Closed blood sampling systems find key applications in treatment procedures for cancer patients calling for infusions in hospital settings and other healthcare facilities. This delivers an opportunity for manufactures to surge their product sales.

The global is projected to witness substantial growth over the forecast period owing to rising demand for safe blood collection procedures for prevention of contamination and infections associated with the environment within healthcare settings. Emerging markets, especially large markets such as India and China, have a significantly large and untapped potential for market expansion.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=4002?PS

Rising adoption of advanced closed systems for blood sampling through variable needle-free access options have been featured in several product offerings by manufacturers. Growing awareness regarding the importance of safe blood transfusion for extending the quality of health as well as outlook of patient life promotes demand for safe blood collection techniques, thus boosting the sales of closed blood monitoring systems.

As per Fact.MR's projections, single-line blood sampling systems held a substantial market share of 25.5% in 2021. Closed blood sampling systems accounted for around 0.3% share of the global blood screening market in 2021.
Sales Analysis of Closed Blood Sampling Systems from 2017 to 2021 Vs Market Outlook for 2022 to 2032

Demand for closed blood sampling systems depends upon the global factors associated with rising measures by healthcare facilities towards comprehensive surgical care. Surgical care is a prime and essential practice to effectively manage a varied range of health conditions. Sales revenue from closed blood sampling systems are expected to increase at a considerable growth rate over the next ten years at a CAGR of 5.9%.

Increasing cases of injury and wound, malignancy, chronic diseases such as cardiovascular diseases and diabetes, obstructed labor, and infections, globally, have accelerated demand for safe and efficient blood sampling techniques, thus posing a positive impact on the growth of the closed blood sampling devices market. The global expanded at 4.8% CAGR over the past 5 years.

𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 𝗳𝗿𝗼𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝘁𝘂𝗱𝘆

• By sampling system, double-line blood sampling systems are expected to hold 28.6% market value share by the end of 2032.
• By modality, pole-mounted sampling systems are expected to hold 63.1% market value share by 2032.
• By age group, adults accounted for 67.8% market value share in 2021.
• Hospitals dominated with a share of 44.4% in 2021.
• By region, North America is set to dominate the global with a value share of around 39.9% by the end of 2032. Europe is slated to be the second-largest leading regional market with a value share of 30.7%.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4002?PS

"High prevalence of needle stick injuries and risk of infections associated with them are set to promote the sales of closed blood sampling systems," says an analyst of Fact.MR.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻

Key market players such as ICU Medical Inc. and Elcam Medical are focusing on development with indication-centric applications for safe blood collection techniques.

• In January 2021, Elcam Medical joined existing investors Alon Medtech and serial medical device inventor, and investor, Dr. Shimon Eckhouse. This venture combines Serenno's solution with Elcam's manufacturing experience to deliver high-quality products at competitive pricing.

Additionally, manufacturers follow acquisition activities in order to build a comprehensive product portfolio and gain operational capacities for production at lower costs.
• In January 2022, Smiths Medical from Smiths Group plc. Was acquired by ICU Medical Inc.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐂𝐥𝐨𝐬𝐞𝐝 𝐁𝐥𝐨𝐨𝐝 𝐒𝐚𝐦𝐩𝐥𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

by Sampling System:

o Single-line Blood Sampling Systems
o Double-Line Blood Sampling Systems
o Triple-Line Blood Sampling Systems
o Pressure Transducer/ Monitoring Kits
o Accessories

by Modality:

o Arm-mounted Sampling Systems
o Pole-mounted Sampling Systems

by Age Group:

o Neonatal/Paediatrics
o Adults

by End User:

o Hospitals
o Specialty Clinics
o Ambulatory Surgical Centres
o Cancer Research Institutes
o Blood Banks
o Others
by Region:

o North America
o Latin America
o Europe
o South Asia
o East Asia
o Oceania
o MEA

𝗚𝗲𝘁 𝗙𝘂𝗹𝗹 𝗔𝗰𝗰𝗲𝘀𝘀 𝗼𝗳 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/checkout/4002

Contact: 

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583E: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.